Search for: "United States v. Buckman"
Results 81 - 100
of 123
Sorted by Relevance
|
Sort by Date
22 Apr 2007, 12:57 am
In Buckman v. [read post]
3 Sep 2014, 9:00 am
United States ex rel. [read post]
18 Feb 2010, 10:34 am
Because those are federal statutes, they can’t be “preempted” the way state-law claims were in Buckman Co. v. [read post]
12 Mar 2009, 7:00 am
The Court in Buckman Co. v. [read post]
12 Feb 2008, 8:29 am
" Buckman Co. v. [read post]
21 Nov 2012, 5:00 am
Wyeth-Ayerst Labs., 385 F.3d 961, 966 (6th Cir. 2004) (holding that a drug manufacturer is immune from suit unless “the FDA itself determines that a fraud has been committed on the agency during the regulatory-approval process”) citing Buckman Co. v. [read post]
16 Sep 2015, 7:05 am
Unilever United States, Inc. [read post]
28 Oct 2015, 4:30 am
Garcia v. [read post]
10 Feb 2012, 8:39 am
The court held otherwise, finding the claims to be “squarely within the parameters” of Buckman Co. v. [read post]
11 Jan 2012, 7:32 am
E.g., United States ex rel. [read post]
12 Jun 2014, 10:46 am
Today the United States Supreme Court ruled in POM Wonderful v. [read post]
31 Jul 2008, 5:30 pm
Accord Phelps v. [read post]
26 Jun 2015, 12:00 pm
United States 14-1145Issue: Whether, under Holland v. [read post]
20 Apr 2010, 6:04 am
Central Regional Employees Benefit Fund v. [read post]
25 Oct 2022, 2:37 pm
See Cruz v. [read post]
30 Apr 2014, 4:30 am
In Williams v. [read post]
24 Mar 2014, 6:34 am
Ct. at 1018; see also United States v. [read post]
5 Apr 2013, 1:01 pm
About the only good thing about Blockis its refusal to allow Parisian to testify directly that the defendant violated the FDCA, that being both an improper legal opinion and barred by Buckman Co. v. [read post]
27 Dec 2007, 7:09 am
It excludes evidence of comparative safety between drugs of the same class, fraud on the FDA (due to Buckman preemption), corporate ethics, and regulatory actions outside of the United States. [read post]
25 Jun 2014, 2:00 pm
United States v. [read post]
